Protein detection method
AssigneeThe Governing Council of the University of Toronto
InventorsJagotamoy DAS, Shana O. Kelley
Life of this patent
Estimating the term…
Abstract
Described herein are systems and methods for detecting a target analyte in a sample with electrodes, comprising a linker and an antibody attached to the linker, and measuring an electrocatalytic signal changes generated by binding of an analyte in the sample to the antibody. Also disclosed herein are kits for electrochemical detection of protein analytes.
Claims24
A method for electrochemical detection of a cancer antigen, comprising:
- providing a nanostructured microelectrode including a linker on its surface, the linker attached to an antibody or fragment thereof and capable of binding the antigen;
- contacting the nanostructured microelectrode with a sample including the antigen and with a redox reporter capable of electron transfer with the microelectrode;
- binding of the antigen to the antibody or fragment thereof, the binding hindering electron transfer between the redox reporter and the nanostructured microelectrode, the nanostructured microelectrode having a diameter of about 100 microns or less, the nanostructured microelectrode having a detection limit for the biomarker from about 0.1 U/ml to about 10 U/ml;
- applying a potential to the nanostructured microelectrode;
- measuring, in response to the applied potential, an electrochemical signal generated by the nanostructured microelectrode;
- comparing the electrochemical signal to a control signal;
- and
- deeming a change of the electrochemical signal detected relative to the control signal as indicative of the presence of the cancer antigen in the sample.
A method for electrochemical detection of a viral antigen, comprising:
- providing a nanostructured microelectrode including a linker on its surface, the linker attached to an antibody or fragment thereof and capable of binding the antigen;
- contacting the nanostructured microelectrode with a sample including the antigen and with a redox reporter capable of electron transfer with the microelectrode;
- binding of the antigen to the antibody or fragment thereof, the binding hindering electron transfer between the redox reporter and the nanostructured microelectrode, the nanostructured microelectrode having a diameter of about 100 microns or less, the nanostructured microelectrode having a detection limit for the antigen from about 0.1 U/ml to about 10 U/ml;
- applying a potential to the nanostructured microelectrode;
- measuring, in response to the applied potential, an electrochemical signal generated by the nanostructured microelectrode;
- comparing the electrochemical signal to a control signal;
- and
- deeming a change of the electrochemical signal detected relative to the control signal as indicative of the presence of the viral antigen in the sample.
A method for electrochemical detection of an antigen, comprising:
- providing a nanostructured microelectrode including a cystamine, cysteamine, mercapto propionic acid or 4-aminothiophenol linker on its surface, the linker attached to an antibody or fragment thereof and capable of binding the antigen;
- contacting the nanostructured microelectrode with a sample including the antigen and with a redox reporter capable of electron transfer with the microelectrode;
- binding of the antigen to the antibody or fragment thereof, the binding hindering electron transfer between the redox reporter and the nanostructured microelectrode, the nanostructured microelectrode having a diameter of about 100 microns or less, the nanostructured microelectrode having a detection limit for the antigen from about 0.1 U/ml to about 10 U/ml;
- applying a potential to the nanostructured microelectrode;
- measuring, in response to the applied potential, an electrochemical signal generated by the nanostructured microelectrode;
- comparing the electrochemical signal to a control signal;
- and
- deeming a change of the electrochemical signal detected relative to the control signal as indicative of the presence of the antigen in the sample.
A method for electrochemical detection of a cancer biomarker, comprising:
- providing a nanostructured microelectrode including a linker on its surface, the linker attached to an antibody or fragment thereof and capable of binding the biomarker;
- contacting the nanostructured microelectrode with a sample including the biomarker and with a redox reporter capable of electron transfer with the microelectrode;
- binding of the biomarker to the antibody or fragment thereof, the binding hindering electron transfer between the redox reporter and the nanostructured microelectrode, the nanostructured microelectrode having a diameter of about 100 microns or less, the nanostructured microelectrode having a detection limit for the biomarker from about 0.1 U/ml to about 10 U/ml;
- applying a potential to the nanostructured microelectrode;
- measuring, in response to the applied potential, an electrochemical signal generated by the nanostructured microelectrode;
- comparing the electrochemical signal to a control signal;
- and
- deeming a change of the electrochemical signal detected relative to the control signal as indicative of the presence of the cancer biomarker in the sample.
A detection system for electrochemically detecting an antigen, comprising:
- (i) a nanostructured microelectrode including a linker on its surface, wherein the nanostructured microelectrode has a diameter of about 100 microns or less and a detection limit for the antigen from about 0.1 U/ml to about 10 U/ml, and wherein the linker is attached to an antibody or fragment thereof capable of binding the antigen;
- and
- (ii) a redox reporter.
Dependencies are inferred from the claim text.